The Parallax View
Subscribe
Sign in
Home
Archive
About
More
return
;
Share this publication
The Parallax View
www.parallax.bio
Copy link
Twitter
Facebook
Email
The Parallax View
Finding unloved, undiscovered, and undervalued biotechs
By Parallax Advisers · Launched a year ago
Subscribe
Login
About
Archive
Top posts
About
Archive
Authors
Login
Let me read it first
$CRTX | Cortexyme
A post-mortem and a look at what’s next
Mar 8
Comment
Cheatsheet: $AUPH | Aurinia
Recapping a year of buyout rumors
Feb 25
1
Comment
CD47: Eating Up Cancer and Biobucks
8,500 words on $TRIL $ALXO $IMAB $STTK $OSE $GILD
Sep 14, 2021
2
Comment
$BNTX | BioNTech: mRNA therapies beyond the COVID-19 vaccine
An exciting approach to auto-immune conditions published in Science shows the broad potential of future mRNA therapies
Feb 14
2
Comment
Most popular
The Biotech Investor's Resources
8
Comment
1
CD47: Eating Up Cancer and Biobucks
2
Comment
You've Been Targeted for Termination
3
Comment
$INFI | Infinity Pharma's bet on PI3K-γ
3
Comment
3
The State of Biotech Today
3
Comment
From Germophobe to Germophile
3
Comment
See all popular
New
Community
The State of Biotech Today
Our world in charts
Feb 9
3
Comment
The Biotech Investor's Resources
Use these to help make $XBI a better place
Jan 18
8
Comment
1
Q3 2021 13F Review + Composite Ticker List
Dec 9, 2021
Comment
1
$GLUE | Monte Rosa Therapeutics
Drugging the undruggable, not redrugging the druggable
Oct 13, 2021
4
Comment
$TLIS | Talis, the Dark Horse of Point-of-Care Testing?
COVID-19 Variant & Flu POCT and the New Normal
Oct 6, 2021
Comment
1
Q2 13F Review
Looking at portfolio changes for RA, Perceptive, Baker, OrbiMed, BVF, EcoR1, Redmile, Opaleye, Ghost Tree
Aug 20, 2021
3
Comment
$CCCC | C4 Therapeutics
2,700 words
Aug 13, 2021
2
Comment
Exclusive: $NRIX | Nurix Therapeutics
1,500 words
Aug 11, 2021
1
Comment
See all
Most popular
The Biotech Investor's Resources
8
Comment
1
CD47: Eating Up Cancer and Biobucks
2
Comment
You've Been Targeted for Termination
3
Comment
$INFI | Infinity Pharma's bet on PI3K-γ
3
Comment
3
The State of Biotech Today
3
Comment
From Germophobe to Germophile
3
Comment
See all popular
The Parallax View
Finding unloved, undiscovered, and undervalued biotechs
Subscribe
The Parallax View
Subscribe
About
Archive
Authors
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
